Cost effectiveness of a protocol using palivizumab in preterm infants

• Principais autores: Yolanda Hernández-Gago (Autor), Marina Lombardero-Pin (Autor), Casilda Ortega de la Cruz (Autor), Pablo A. Maciuniak (Autor), Alicia Díez del Pino (Autor)
• Formato: Livro
• Publicado em: Elsevier, 2017-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

<p><strong>Objective:</strong> The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary objective risk fac...